Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Disparities and Their Impact on the Adoption of Health Information Technology (HIT) in Minority Cancer Patients and Caregivers

Sikander Ailawadhi, MD, Meghna Ailawadhi, MD, Srilekha Bodepudi, Mays F Abdulazeez, BMSC, Zan Tahir Shareef, Ashna Grover, Maria J Fernandez, Winston Tan, MD, Victoria R. Alegria, Taimur Sher, MD, Vivek Roy, MD, Rami Manochakian, MD, Aneel Paulus, MD, Asher A. Chanan-Khan, MD

Blood (2019) 134 (Supplement_1): 411.

https://doi.org/10.1182/blood-2019-125722

Published: 2019

Journal Articles

Home-Based Assessment of Patient Reported Outcome Measures Using a Smartphone App Platform: A Feasibility Study

Sherif M. Badawy, MD, Leonardo Barrera, MPH, Graham Zolkowski, BS, Zeinab Alward, MBChB, MPH

Blood (2019) 134 (Supplement_1): 420.

https://doi.org/10.1182/blood-2019-131334

Published: 2019

Journal Articles

Age and Time to Progression Predict Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Who Progress Following Frontline Immunochemotherapy (IC)

Blood (2019) 134 (Supplement_1): 400.

https://doi.org/10.1182/blood-2019-124017

Published: 2019

Journal Articles

The Effects of Text Messaging for Promoting the Retention of the First-Time Blood Donors, a Randomized Controlled Study (TEXT study)

Chontara Pongsananurak, MD, Lalita Norasetthada, MD, Adisak Tantiworawit, MD, Ekarat Rattarittamrong, MD, Thanawat Rattanathammethee, MD, Maitree Sriwichai, ฺBSc, Nipapan Leetrakool, MSc, Pokpong Piriyakhuntorn, MD, Sasinee Hantrakool, MD, Chatree Chai-Adisaksopha, MD PhD

Blood (2019) 134 (Supplement_1): 2453.

https://doi.org/10.1182/blood-2019-122538

Published: 2019

Journal Articles

A Prospective Phase II, Open-Label, Single-Arm, Multicenter Study to Assess the Efficacy and Safety of SEG101 (Crizanlizumab) in Sickle Cell Disease Patients with Priapism (SPARTAN)

Fuad A El Rassi, MD, Deepika S. Darbari, MD, Arthur Burnett, MD MBA, Jincy Paulose, MD, Dramane I Laine, Das Purkayastha, PhD, Gregory J Kato, MD

Blood (2019) 134 (Supplement_1): 1007.

https://doi.org/10.1182/blood-2019-125790

Published: 2019

Journal Articles

Education Program to Improve the Adherence to Guidelines for Use of Blood Transfusions in Sickle Cell Disease

Jennel Zeppieri, MD BSc, Dongyoun Deborah Park, MD BA, Kelley Mowatt, DO, Mohammed Sharif, MD, Alice J. Cohen, MD

Blood (2019) 134 (Supplement_1): 2115.

https://doi.org/10.1182/blood-2019-131766

Published: 2019

Journal Articles

Long-Term Proteasome Inhibitor (PI) Therapy in Community Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Transitioning from Bortezomib (Btz)-Based to Ixazomib-Based Induction: Results from the US MM-6 Study in the Real World (RW) Setting

Robert M. Rifkin, MD, Sudhir Manda, MD, Stephen J Noga, MD PhD, Habte A Yimer, MD, Saulius K. Girnius, MD, Ruemu Ejedafeta Birhiray, MD, Christopher A. Yasenchak, MD, Roger M. Lyons, MD, Presley Whidden, Robert L. Schlossman, MD, Bingxia Wang, PhD, Ralph V. Boccia, MD

Blood (2019) 134 (Supplement_1): 1882.

https://doi.org/10.1182/blood-2019-124747

Published: 2019

Journal Articles

Towards Higher Safety of Haemato-Oncological Patients Undergoing Treatment

Tereza Popkova, MD, Katarina Hradska, MD, Jana Mihalyova, MD, Michaela Skorupova, Tomas Jelinek, MD, Juraj Duras, MD, Zdenek Koristek, MD PhD, Milan Navratil, MD, Katerina Benkova, MD, Hana Plonkova, MD, Jana Zuchnicka, MD, Jaromir Gumulec, MD, Roman Hajek, Prof, MD PhD

Blood (2019) 134 (Supplement_1): 4757.

https://doi.org/10.1182/blood-2019-127011

Published: 2019

Journal Articles

Not All Patients with Mild Phenotype of Gaucher Disease (GD) Need Disease Specific Treatment As Reflected By Patients Reported Outcomes Measures

Shoshana Revel-Vilk, MD, Tama Dinur, PhD, Majdolen Istaiti, Dafna Frydman, DMV, Michal Becker-Cohen, MSc, Ari Zimran, MD

Blood (2019) 134 (Supplement_1): 4712.

https://doi.org/10.1182/blood-2019-123000

Published: 2019

Journal Articles

Real-World (RW) Treatment Patterns and Patient-Related Factors Including Quality of Life (QoL), Medication Adherence, and Actigraphy in Community Patients (pts) with Newly Diagnosed Multiple Myeloma (NDMM) Transitioning from Bortezomib (btz) to Ixazomib: The US MM-6 Community-Based Study

Stephen J Noga, MD PhD, Robert M. Rifkin, MD, Sudhir Manda, MD, Ruemu Ejedafeta Birhiray, MD, Roger M. Lyons, MD, Presley Whidden, Robert L. Schlossman, MD, Bingxia Wang, PhD, Ralph V. Boccia, MD

Blood (2019) 134 (Supplement_1): 3168.

https://doi.org/10.1182/blood-2019-124784

Published: 2019

Journal Articles

Pharmacokinetics of Extended Half-Life Factor VIII Products By myPKFiT R Is Useful for Personalized Treatment in Children with Severe Hemophilia a

Risa Matsumura, Keita Tomioka, MD, Shiho Nishimura, MD, Yoko Mizoguchi, MD PhD, Hiroshi Kawaguchi, MD PhD, Masao Kobayashi, MD PhD

Blood (2019) 134 (Supplement_1): 1127.

https://doi.org/10.1182/blood-2019-128149

Published: 2019

Journal Articles

Impact of Mhealth and Ehealth Applications on Hemophilia Treatment Management

Maria Margalida Santandreu Estelrich, MD, José María Sánchez-Raga, MD, Antonio Palomero Massanet, Bernat Galmés Sureda, Olga Delgado, MD, Antonia Sampol, MD PhD, Mariana Canaro, PhD MD

Blood (2018) 132 (Supplement 1): 5038.

https://doi.org/10.1182/blood-2018-99-119139

Published: 2018

Journal Articles

Harnessing the Power of Global Health Studies for Sickle Cell Disease: Validation of a Rapid, Open-Source, Paper-Based Screening Assay in a Cohort of 1103 Tanzanian Children

Julien Delobel, PhD, Kristina Keitel, MDPhD, Katia Balmas-Bourloud, Tarsis Mlaganile, Valerie D'Acremont, MDPhD, Raffaele Renella, MD PhD

Blood (2018) 132 (Supplement 1): 510.

https://doi.org/10.1182/blood-2018-99-109726

Published: 2018

Journal Articles

Assisted Administration of Subcutaneous Rituximab to the Patient's Home. Significant Reduction of Indirect Costs Incurred By Care Recipients and Unpaid Caregivers Together with a Total Adherence to the Treatment Schedule and Same Safety

Francesco Iuliano, MD, Eleonora Iuliano, MD, Marco Rossi, MD

Blood (2018) 132 (Supplement 1): 5869.

https://doi.org/10.1182/blood-2018-99-118756

Published: 2018

Journal Articles

Identifying Neutropenic Fever Earlier: An Application of a Skin Patch for Continuous Temperature Monitoring

Nina Dambrosio, CNP, Molly Porter, CNP, Erica Bauer, RN, Nathan Levitan, MD, Deborah Liedtke, RN, Marcos de Lima, MD, Ehsan Malek, MD

Blood (2018) 132 (Supplement 1): 4718.

https://doi.org/10.1182/blood-2018-99-114181

Published: 2018

Journal Articles

Continuous Mobile Wearable Bio-Monitoring of Newly Diagnosed Multiple Myeloma Patients Undergoing Initial Chemotherapy

Blood (2018) 132 (Supplement 1): 4751.

https://doi.org/10.1182/blood-2018-99-116545

Published: 2018

Journal Articles

Association between Patient-Reported Outcomes and Physical Activity Measured on the Apple Watch in Patients with Hematological Malignancies

Carrie A Thompson, MD, Paul Novotny, Jeff A. Sloan, PhD, Alicia Bartz, Kathleen Yost, PhD

Blood (2017) 130 (Supplement 1): 2179.

https://doi.org/10.1182/blood.V130.Suppl_1.2179.2179

Published: 2017

Journal Articles

Feasibility of a Smartphone Application (App) Pictorial Blood Assessment Chart (PBAC) As an Endpoint in a Von Willebrand Disease Trial

Shawn Tahata, BS, BA, Margaret V. Ragni, MD MPH, Judith Kadosh, BSN RN

Blood (2017) 130 (Supplement 1): 3684.

https://doi.org/10.1182/blood.V130.Suppl_1.3684.3684

Published: 2017

Journal Articles

Mobile Application Vs. Paper Pictorial Blood Assessment Chart to Track Menses in Young Women: A Randomized Cross-over Design

Amanda E. Jacobson, MD, Sara K. Vesely, PhD, Myra Christian-Rancy, Sarah H. O'Brien, MD MSc

Blood (2016) 128 (22): 1006.

https://doi.org/10.1182/blood.V128.22.1006.1006

Published: 2016

Journal Articles

Feasibility of a Smartphone-Based Health Coaching Intervention for Patient Self-Management of Nutrition in the Post-Chemotherapy Setting

Connie E Chen, MD, Alice Y Mao, Jontrice G Murray, Betul Oran, MD, Muzaffar H. Qazilbash, MD, Nina Shah, MD, Sairah Ahmed, MD, Qaiser Bashir, MD, Chitra Hosing, MD, Elizabeth J. Shpall, MD, Joseph R Steele, MD, Richard E. Champlin, MD, Simrit Parmar, MD

Blood (2016) 128 (22): 3554.

https://doi.org/10.1182/blood.V128.22.3554.3554

Published: 2016

NARROW

Disparities and Their Impact on the Adoption of Health Information Technology (HIT) in Minority Cancer Patients and Caregivers

Home-Based Assessment of Patient Reported Outcome Measures Using a Smartphone App Platform: A Feasibility Study

Age and Time to Progression Predict Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Who Progress Following Frontline Immunochemotherapy (IC)

The Effects of Text Messaging for Promoting the Retention of the First-Time Blood Donors, a Randomized Controlled Study (TEXT study)

A Prospective Phase II, Open-Label, Single-Arm, Multicenter Study to Assess the Efficacy and Safety of SEG101 (Crizanlizumab) in Sickle Cell Disease Patients with Priapism (SPARTAN)

Education Program to Improve the Adherence to Guidelines for Use of Blood Transfusions in Sickle Cell Disease

Long-Term Proteasome Inhibitor (PI) Therapy in Community Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Transitioning from Bortezomib (Btz)-Based to Ixazomib-Based Induction: Results from the US MM-6 Study in the Real World (RW) Setting

Towards Higher Safety of Haemato-Oncological Patients Undergoing Treatment

Not All Patients with Mild Phenotype of Gaucher Disease (GD) Need Disease Specific Treatment As Reflected By Patients Reported Outcomes Measures

Real-World (RW) Treatment Patterns and Patient-Related Factors Including Quality of Life (QoL), Medication Adherence, and Actigraphy in Community Patients (pts) with Newly Diagnosed Multiple Myeloma (NDMM) Transitioning from Bortezomib (btz) to Ixazomib: The US MM-6 Community-Based Study

Pharmacokinetics of Extended Half-Life Factor VIII Products By myPKFiT R Is Useful for Personalized Treatment in Children with Severe Hemophilia a

Impact of Mhealth and Ehealth Applications on Hemophilia Treatment Management

Harnessing the Power of Global Health Studies for Sickle Cell Disease: Validation of a Rapid, Open-Source, Paper-Based Screening Assay in a Cohort of 1103 Tanzanian Children

Assisted Administration of Subcutaneous Rituximab to the Patient's Home. Significant Reduction of Indirect Costs Incurred By Care Recipients and Unpaid Caregivers Together with a Total Adherence to the Treatment Schedule and Same Safety

Identifying Neutropenic Fever Earlier: An Application of a Skin Patch for Continuous Temperature Monitoring

Continuous Mobile Wearable Bio-Monitoring of Newly Diagnosed Multiple Myeloma Patients Undergoing Initial Chemotherapy

Association between Patient-Reported Outcomes and Physical Activity Measured on the Apple Watch in Patients with Hematological Malignancies

Feasibility of a Smartphone Application (App) Pictorial Blood Assessment Chart (PBAC) As an Endpoint in a Von Willebrand Disease Trial

Mobile Application Vs. Paper Pictorial Blood Assessment Chart to Track Menses in Young Women: A Randomized Cross-over Design

Feasibility of a Smartphone-Based Health Coaching Intervention for Patient Self-Management of Nutrition in the Post-Chemotherapy Setting

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only